PATENT CLAIM ANALYSIS

Application Number: 15887523
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "451000"]

Abstract:
The present invention relates generally to the field of using udenafil or a pharmaceutically acceptable salt thereof in patients who have undergone the Fontan operation.

Claim (Index 35):
The method of  claim 34 , wherein the oral dosage form is a tablet.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 88.0
- Lexical Diversity: 1.04
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14788211', '15197209', '14079548', '14442711', '15853248']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.635094243352617
- 35 USC 102 Novelty (BERT): 0.6864400742067636
- Combined Prediction Score: 0.6402288264380317
- Mean Citation Score: 327.00605399999995
- Max Citation Score: 868.9675
- Similarity Product: 644.5936260548234

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test